Chemicals and pharmaceuticals · NEXI

NexImmune, Inc.

6 filings mentioning 5 of the compliance and risk topics we track. Every row links to the filing on EDGAR.

6filings we hold
5topics disclosed
Chemicals and pharmaceuticalsindustry
MDbased in

Across 6 filings we hold, NexImmune, Inc. has written down 5 of the topics we track. That places it 562 of 737 companies we hold in chemicals and pharmaceuticals, by how much we have collected.

NEXI Chemicals and pharmaceuticals

What this obligates

Every instrument in our corpus that governs something NexImmune, Inc. has written into a filing. Not what they said. What applies once they have said it.

NIST Cybersecurity Framework 2.078
ISO/IEC 42001:202361
ISO 27001:202242
NIST AI Risk Management Framework (AI RMF 1.0)41
ASD Strategies to Mitigate Cyber Security Incidents29
Colorado Artificial Intelligence Act (proposed SB 24-205)16
EU AI Act15
COSO Internal Control9
OECD Recommendation on Artificial Intelligence (2024 Update)8
NIST SP 800-615

10 frameworks, 304 controls between them, deduplicated across topics.

What it discloses

Tracked topics appearing in this company's filings, most frequent first.

Restatement2
Internal Control2
Audit Committee Oversight1
Artificial Intelligence1
Ransomware1

Bars are scaled against this company's most frequent topic, not against the market. The table below has the exact counts.

TopicFilingsMost recent
Restatement22022-06-17
Internal Control22024-02-05
Audit Committee Oversight12021-11-12
Artificial Intelligence12022-03-17
Ransomware12024-04-16

When it filed

Filings we hold, by year. Hover a bar for the count.

21
22
23
24

Recent filings

FiledFormItem
2024-04-1610-Kfiling
2024-02-058-KEntry into a material agreement, Item 3.02, Shareholder votefiling
2022-06-178-KEntry into a material agreement, Financial statements and exhibitsfiling
2022-03-178-KEntry into a material agreement, Regulation FD disclosure, Financial statements and exhibitsfiling
2021-11-1210-Qfiling
2021-02-188-KItem 5.03, Other material event, Financial statements and exhibitsfiling

Others in chemicals and pharmaceuticals

The companies we hold most on in the same industry. Each opens side by side with this one.

CompanyFilings
OPKOPKO HEALTH, INC.12compare →
FGENFIBROGEN INC12compare →
PTNPALATIN TECHNOLOGIES INC12compare →
OTLCOncotelic Therapeutics, Inc.12compare →
NKTRNEKTAR THERAPEUTICS12compare →
APALEXION PHARMACEUTICALS, INC.12compare →
New here? Signals tracks the compliance and risk language public companies put into their SEC filings, and cross-references it against 723 frameworks and 20,473 controls. See what moved today or check how much of a framework you already cover.

What this page is

Every row comes from SEC full-text search over this company's filings, matched against the compliance and risk phrases we track. It is a record of what the company itself wrote down in documents it is legally accountable for. It is not an assessment of the company, a rating, or a claim about how well it manages anything.

A phrase appearing in a filing frequently means the risk section mentions it, not that an event occurred. Where an item number indicates an actual event, the Item column says so.

All of chemicals and pharmaceuticals · All companies · Today's edition